Home

About Us

Technology Platform

Our Pipeline

For Patients

Information Center

Contact Us

Ch

Information Center
29.06 2022
BD111 of BDgene passed the FDA orphan drug application
BD111 of BDgene passed the FDA orphan drug application
08.02 2022
BDgene Appoints Dr. Lin Zhang as Senior Vice President
BDgene Appoints Dr. Lin Zhang as Senior Vice President
24.01 2022
Breakthrough in gene therapy for age-related macular degeneration
Breakthrough in gene therapy for age-related macular degeneration
07.01 2022
The first domestic case of "Treatment of Double β0 Severe Thalassemia with Lentiviral Gene Modificat
The first domestic case of "Treatment of Double β0 Severe Thalassemia with Lentiviral Gene Modificat
10.11 2021
BDgene is signed with the Minhang Development Zone, and the headquarters base settled in the area.
BDgene is signed with the Minhang Development Zone, and the headquarters base settled in the area.
06.10 2021
Open a new chapter! BDgene won the "Star Awards-2021 China Bio-Innovative Drug Most Growth Annual Aw
Open a new chapter! BDgene won the "Star Awards-2021 China Bio-Innovative Drug Most Growth Annual Aw
010203
logo
About Us
Technology Platform
Our Pipeline
Information Center
Contact Us
info@bdgene.cn

Email

Building 10, No.55 Bixi Road, Minhang District, Shanghai,China

ADD
Copyright@2021-2025 Shanghai BDgene Co. Ltd.， 沪ICP备19001521号-1

open

close